Skip to main content

Estimated Prevalence of Glomerular Diseases: An Updated Descriptive Analysis

    Basic Details
    Date Posted
    Status
    Complete
    Health Outcome(s)
    glomerular diseases
    Description

    In this analysis, we counted and described individuals in the Sentinel Distributed Database (SDD) with various glomerular diseases defined using various code-lists and algorithms. This analysis includes two reports:

    • Report 1: We examined individuals with immunoglobulin A (IgA) nephropathy. The study period includes data from October 1, 2016 to October 31, 2020. We distributed this request to seven Sentinel Data Partners on May 19, 2021.
    • Report 2: We examined individuals with focal segmental glomerulosclerosis, membranous nephropathy, minimal change disease, membranoproliferative glomerulonephritis, crescentic/necrotizing glomerulonephritis, lupus nephritis, diabetic nephropathy, and nephrotic syndrome. The study period includes data from October 1, 2016 to May 10, 2021. We distributed this request to seven Sentinel Data Partners on September 10, 2021. 
    Additional Details
    FDA Center
    CDER
    Time Period
    October 1, 2016 - October 31, 2020; October 1, 2016 - May 10, 2021
    Analysis Type
    Descriptive
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)